Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, 4A Datun Road, Beijing 100101, China.
Schizophr Bull. 2010 Nov;36(6):1089-104. doi: 10.1093/schbul/sbp011. Epub 2009 Apr 17.
Neurological soft signs (NSS) are hypothesized as candidate endophenotypes for schizophrenia, but their prevalence and relations with clinical and demographic data are unknown. The authors undertook a quantification (meta-analysis) of the published literature on NSS in patients with schizophrenia and healthy controls. A systematic search was conducted for published articles reporting NSS and related data using standard measures in schizophrenia and healthy comparison groups.
A systematic search was conducted for published articles reporting data on the prevalence of NSS in schizophrenia using standard clinical rating scales and healthy comparison groups. Meta-analyses were performed using the Comprehensive Meta-analysis software package. Effect sizes (Cohen d) indexing the difference between schizophrenic patients and the healthy controls were calculated on the basis of reported statistics. Potential moderator variables evaluated included age of patient samples, level of education, sample sex proportions, medication doses, and negative and positive symptoms.
A total of 33 articles met inclusion criteria for the meta-analysis. A large and reliable group difference (Cohen d) indicated that, on average, a majority of patients (73%) perform outside the range of healthy subjects on aggregate NSS measures. Cognitive performance and positive and negative symptoms share 2%-10% of their variance with NSS.
NSS occur in a majority of the schizophrenia patient population and are largely distinct from symptomatic and cognitive features of the illness.
神经学软体征(NSS)被假设为精神分裂症的候选内表型,但它们的患病率及其与临床和人口统计学数据的关系尚不清楚。作者对精神分裂症患者和健康对照组中 NSS 的已发表文献进行了量化(荟萃分析)。使用精神分裂症和健康对照组的标准测量方法,对报告 NSS 及相关数据的已发表文章进行了系统搜索。
使用标准临床评分量表和健康对照组,对报告 NSS 患病率的精神分裂症患者的已发表文章进行了系统搜索。使用 Comprehensive Meta-analysis 软件包进行荟萃分析。根据报告的统计数据,计算了以 Cohen d 表示的精神分裂症患者与健康对照组之间差异的效应量。评估的潜在调节变量包括患者样本的年龄、教育水平、样本性别比例、药物剂量以及阴性和阳性症状。
共有 33 篇文章符合荟萃分析的纳入标准。较大且可靠的组间差异(Cohen d)表明,总体而言,大多数患者(73%)的 NSS 平均值超出了健康受试者的范围。认知表现以及阳性和阴性症状与 NSS 共享 2%-10%的方差。
NSS 发生在大多数精神分裂症患者群体中,与疾病的症状和认知特征有很大不同。